Search

everythinglearnresearchcommunity

for

Search:↓

Women with lupus experienced non-scarring hair loss with fewer hair follicles, and the test for lupus in hair was not helpful.

Hidradenitis suppurativa may mainly affect vellus hair follicles, not terminal ones.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Alopecic and aseptic nodules of the scalp are rare, treatable, and often resolve with doxycycline or on their own.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

A young man was unexpectedly diagnosed with basal cell carcinoma after a scalp examination and confocal microscopy.

CD34 is absent in most basal cell carcinoma cells but present in surrounding skin.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

EF and PXE not closely related.

A man's skin cancer improved and some of his hair grew back after treatment with a special light therapy and a medication.

Lichen planopilaris patients are more likely to have hypothyroidism.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Androgen receptors significantly affect hair loss in women with androgenetic alopecia.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Nivolumab can cause hair loss as a rare side effect.

ILC1-like cells can independently cause alopecia areata.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Targeting the AhR pathway may help treat alopecia areata.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

Topical minoxidil improves hair loss in 80% of women with breast cancer undergoing endocrine therapy.

Tumid lupus erythematosus can cause non-scarring hair loss on the scalp and requires careful diagnosis.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Acne keloidalis nuchae is a tough-to-treat condition that greatly affects quality of life, especially in men of African descent.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

Melanoma thickness at diagnosis is linked to access to dermatologists and preventive services, not to socioeconomic status.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

EGFR inhibitors can cause unusual localized hair growth.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.